Meeting of the National Clinical Care Commission, 5671 [2020-01871]
Download as PDF
Federal Register / Vol. 85, No. 21 / Friday, January 31, 2020 / Notices
During the March 2–4, 2020, meeting,
NACRHHS will examine two topics:
Maternal and Obstetric Care Challenges
in Rural America and HIV Prevention
and Treatment Challenges in Rural
America. Refer to the NACRHHS
website for any updated information
concerning the meeting.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting. Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to NACRHHS
should be sent to Steven Hirsch, using
the contact information above, at least 3
business days prior to the meeting.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Steven Hirsch at the address and
phone number listed above at least 10
business days prior to the meeting.
Since the meeting at the CDC occurs in
a federal government building,
attendees must go through a security
check to enter the building. Non-U.S.
Citizen attendees must notify Steven
Hirsch of their planned attendance at
least 20 business days prior to the
meeting in order to facilitate their entry
into the building. All attendees are
required to present government-issued
identification prior to entry.
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2020–01810 Filed 1–30–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Clinical Care
Commission
Office of Disease Prevention
and Health Promotion, Office of the
Assistant Secretary for Health, Office of
the Secretary, Department of Health and
Human Services.
AGENCY:
ACTION:
Notice.
The National Clinical Care
Commission (the Commission) will
conduct a virtual meeting on February
19, 2020. The Commission is charged to
evaluate and make recommendations to
the U.S. Department of Health and
Human Services (HHS) Secretary and
Congress regarding improvements to the
coordination and leveraging of federal
programs related to diabetes and its
complications.
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:16 Jan 30, 2020
Jkt 250001
The meeting will take place on
February 19, 2020, from 1 p.m. to
approximately 5 p.m. Eastern Standard
Time (EST).
ADDRESSES: The meeting will be held
online via webinar. To register to attend
the meeting, please visit the registration
website at https://
kauffmaninc.adobeconnect.com/nccc_
feb2020/event/event_info.html.
FOR FURTHER INFORMATION CONTACT:
Linda Harris, Designated Federal
Officer, National Clinical Care
Commission, U.S. Department of Health
and Human Services, Office of the
Assistant Secretary for Health, Office of
Disease Prevention and Health
Promotion, 1101 Wootton Parkway,
Suite 420, Rockville, MD 20852. Email:
OHQ@hhs.gov. Telephone: 240–453–
8262.
SUPPLEMENTARY INFORMATION: The
National Clinical Care Commission Act
(Pub. L. 115–80) requires the HHS
Secretary to establish the National
Clinical Care Commission. The
Commission consists of representatives
of specific federal agencies and nonfederal individuals and entities who
represent diverse disciplines and views.
The Commission will evaluate and
make recommendations to the HHS
Secretary and Congress regarding
improvements to the coordination and
leveraging of federal programs related to
diabetes and its complications.
The sixth meeting will be held
virtually, and will consist of
presentations from the Centers for
Medicare and Medicaid Services (CMS).
The final meeting agenda will be
available prior to the meeting at https://
health.gov/hcq/national-clinical-carecommission.asp.
Public Participation at Meeting: The
Commission invites public comment on
issues related to the Commission’s
charge. There will be an opportunity for
oral comments at this virtual meeting.
Virtual attendees who plan to provide
oral comments at the Commission
meeting during a designated time must
register prior to the meeting. To
virtually attend the Commission
meeting, individuals must pre-register at
the registration website at https://
kauffmaninc.adobeconnect.com/nccc_
feb2020/event/event_info.html.
Written comments are welcome
throughout the entire development
process of the Commission’s work and
may be emailed to OHQ@hhs.gov, or by
mail to the following address: Public
Commentary, National Clinical Care
Commission, 1101 Wootton Parkway,
Suite 420, Rockville, MD 20852. Written
comments should not exceed three
pages in length.
DATES:
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
5671
Individuals who need special
assistance with reasonable
accommodations, should indicate the
special accommodation when
registering online or by notifying
Jennifer Gillissen at jennifer.gillissen@
kauffmaninc.com by February 7, 2020.
Authority: The National Clinical Care
Commission is required under the
National Clinical Care Commission Act
(Pub. L. 115–80). The Commission is
governed by provisions of the Federal
Advisory Committee Act (FACA), Public
Law 92–463, as amended (5 U.S.C.,
App.) which sets forth standards for the
formation and use of federal advisory
committees.
Dated: January 23, 2020.
Donald Wright,
Deputy Assistant Secretary for Health.
[FR Doc. 2020–01871 Filed 1–30–20; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on Combating AntibioticResistant Bacteria
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that a meeting is scheduled to be held
for the Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria
(PACCARB). The meeting will be open
to the public; a public comment session
will be held during the meeting. Preregistration is required for members of
the public who wish to attend the
meeting and who wish to participate in
the public comment session. Individuals
who wish to attend the meeting and/or
send in their public comment via email
should send an email to CARB@hhs.gov.
Registration information is available on
the website https://www.hhs.gov/paccarb
and must be completed by February 19,
2020; all in-person attendees must preregister by this date. Additional
information about registering for the
meeting and providing public comment
can be obtained at https://www.hhs.gov/
paccarb on the Meetings page.
DATES: The meeting is scheduled to be
held on February 26, 2020, from 9:00
a.m. to 4:30 p.m. and February 27, 2020,
from 9:00 a.m. to 4:00 p.m. ET (times are
tentative and subject to change). The
confirmed times and agenda items for
SUMMARY:
E:\FR\FM\31JAN1.SGM
31JAN1
Agencies
[Federal Register Volume 85, Number 21 (Friday, January 31, 2020)]
[Notices]
[Page 5671]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01871]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Clinical Care Commission
AGENCY: Office of Disease Prevention and Health Promotion, Office of
the Assistant Secretary for Health, Office of the Secretary, Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Clinical Care Commission (the Commission) will
conduct a virtual meeting on February 19, 2020. The Commission is
charged to evaluate and make recommendations to the U.S. Department of
Health and Human Services (HHS) Secretary and Congress regarding
improvements to the coordination and leveraging of federal programs
related to diabetes and its complications.
DATES: The meeting will take place on February 19, 2020, from 1 p.m. to
approximately 5 p.m. Eastern Standard Time (EST).
ADDRESSES: The meeting will be held online via webinar. To register to
attend the meeting, please visit the registration website at https://kauffmaninc.adobeconnect.com/nccc_feb2020/event/event_info.html.
FOR FURTHER INFORMATION CONTACT: Linda Harris, Designated Federal
Officer, National Clinical Care Commission, U.S. Department of Health
and Human Services, Office of the Assistant Secretary for Health,
Office of Disease Prevention and Health Promotion, 1101 Wootton
Parkway, Suite 420, Rockville, MD 20852. Email: [email protected]. Telephone:
240-453-8262.
SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act
(Pub. L. 115-80) requires the HHS Secretary to establish the National
Clinical Care Commission. The Commission consists of representatives of
specific federal agencies and non-federal individuals and entities who
represent diverse disciplines and views. The Commission will evaluate
and make recommendations to the HHS Secretary and Congress regarding
improvements to the coordination and leveraging of federal programs
related to diabetes and its complications.
The sixth meeting will be held virtually, and will consist of
presentations from the Centers for Medicare and Medicaid Services
(CMS). The final meeting agenda will be available prior to the meeting
at https://health.gov/hcq/national-clinical-care-commission.asp.
Public Participation at Meeting: The Commission invites public
comment on issues related to the Commission's charge. There will be an
opportunity for oral comments at this virtual meeting. Virtual
attendees who plan to provide oral comments at the Commission meeting
during a designated time must register prior to the meeting. To
virtually attend the Commission meeting, individuals must pre-register
at the registration website at https://kauffmaninc.adobeconnect.com/nccc_feb2020/event/event_info.html.
Written comments are welcome throughout the entire development
process of the Commission's work and may be emailed to [email protected], or
by mail to the following address: Public Commentary, National Clinical
Care Commission, 1101 Wootton Parkway, Suite 420, Rockville, MD 20852.
Written comments should not exceed three pages in length.
Individuals who need special assistance with reasonable
accommodations, should indicate the special accommodation when
registering online or by notifying Jennifer Gillissen at
[email protected] by February 7, 2020.
Authority: The National Clinical Care Commission is required under
the National Clinical Care Commission Act (Pub. L. 115-80). The
Commission is governed by provisions of the Federal Advisory Committee
Act (FACA), Public Law 92-463, as amended (5 U.S.C., App.) which sets
forth standards for the formation and use of federal advisory
committees.
Dated: January 23, 2020.
Donald Wright,
Deputy Assistant Secretary for Health.
[FR Doc. 2020-01871 Filed 1-30-20; 8:45 am]
BILLING CODE 4150-32-P